At present, the developing novel drug for the treatment of Idiopathic Pulmonary Fibrosis (IPF) is targeted regulation of TGF-β signaling, and there is no similar competitive product in the world. The drug has now completed the pre-clinical research (GMP production and GLP safety assessment), and we are going to submit the application of first-in-c...
HTPEP-001, a new drug being developed by the company, was once again recognized by the international authoritative academic conference
2020-09-24
6212017-02-07
282Talent first, welcome to huitai home。
人才第一 talent and capacity
诚信利他 Honesty and altruism
专业精准 Profession and accuracy
协作赋能 Cooperation and empowerment
奋斗共赢 Loyalty and mutual-benefit
